Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Long-term Prognosis in Erdheim-Chester Disease: A New Comprehensive Approach

NCT07454343 is registered in ClinicalTrials.gov with Meyer Children's Hospital IRCCS as lead sponsor.

NCT NCT07454343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07454343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Long-term Prognosis in Erdheim-Chester Disease: A New Comprehensive Approach
Lead sponsor
Meyer Children's Hospital IRCCS
Phase
Observational
Overall status
Recruiting
Start date
December 23, 2024
Completion date
December 31, 2028
Enrollment
1,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

erdheim-chester disease (ecd)